• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在英格兰和威尔士照顾艾滋病毒感染者及艾滋病患者的经济成本。

The economic costs of caring for people with HIV infection and AIDS in England and Wales.

作者信息

Petrou S, Dooley M, Whitaker L, Beck E, Kupek E, Wadsworth J, Miller D, Renton A

机构信息

Academic Department of Public Health, St Mary's Hospital Medical School, London, England.

出版信息

Pharmacoeconomics. 1996 Apr;9(4):332-40. doi: 10.2165/00019053-199609040-00006.

DOI:10.2165/00019053-199609040-00006
PMID:10160107
Abstract

The objectives of this study were firstly to estimate total lifetime care costs for an individual with HIV/AIDS, and secondly to estimate the total costs of caring people with HIV infection and AIDS in England and Wales between 1992 and 1997 inclusive. Questionnaires and monthly diaries were used to collate data on healthcare utilisation from patients with HIV infection over a 6-month period. These data were then used to estimate the annual total direct costs of care (stratified by disease stage), total lifetime costs of care, and present and future total national care costs for England and Wales. Costing data were obtained from providers of services throughout Greater London. In total, 235 patients with HIV infection were recruited from 2 clinics in Greater London. All costs were calculated in 1992-93 pounds sterling (pound; 1 pound = $US1.58, December 1995). Annual care costs were estimated at 4515 pounds ($US7134) for a person with asymptomatic HIV disease, 8836 pounds ($US13,961) for a person with symptomatic non-AIDS and 15 268 pounds ($US24,123) for a person with AIDS. Lifetime care costs were estimated at 84,522 pounds ($US133,545) per patient. The total costs of care for England and Wales were forecast to increase from 116,627,400 pounds ($US184,271,300) in 1992 to 162,638,100 pounds ($US256,968,200) in 1997. In conclusion, our study further emphasises the continued shift in hospital services from the inpatient sector to the outpatient sector. The importance of community care and informal care, in terms of the associated direct economic costs, is also highlighted. This emphasises the need for close collaboration between different agencies and strategic coordination of services. Finally, the study forecasts an increase in care costs in England and Wales during the 1990s.

摘要

本研究的目标,一是估算一名艾滋病毒/艾滋病患者一生的护理总成本,二是估算1992年至1997年(含)期间英格兰和威尔士护理艾滋病毒感染者及艾滋病患者的总成本。通过问卷调查和月度日志收集了艾滋病毒感染者在6个月期间的医疗保健利用数据。这些数据随后被用于估算年度护理总直接成本(按疾病阶段分层)、护理一生的总成本,以及英格兰和威尔士当前及未来的全国护理总成本。成本核算数据来自大伦敦地区的服务提供商。总共从大伦敦的2家诊所招募了235名艾滋病毒感染者。所有成本均以1992 - 1993年英镑计算(1英镑 = 1.58美元,1995年12月)。无症状艾滋病毒感染者的年度护理成本估计为4515英镑(7134美元),有症状非艾滋病患者为8836英镑(13961美元),艾滋病患者为15268英镑(24123美元)。每位患者一生的护理成本估计为84522英镑(133545美元)。预计英格兰和威尔士的护理总成本将从1992年的116627400英镑(184271300美元)增至1997年的162638100英镑(256968200美元)。总之,我们的研究进一步强调了医院服务从住院部门持续向门诊部门转移。社区护理和非正式护理在相关直接经济成本方面的重要性也得到了凸显。这强调了不同机构之间密切合作以及服务战略协调的必要性。最后,该研究预测20世纪90年代英格兰和威尔士的护理成本将会增加。

相似文献

1
The economic costs of caring for people with HIV infection and AIDS in England and Wales.在英格兰和威尔士照顾艾滋病毒感染者及艾滋病患者的经济成本。
Pharmacoeconomics. 1996 Apr;9(4):332-40. doi: 10.2165/00019053-199609040-00006.
2
Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.英国一家艾滋病病毒转诊中心为感染艾滋病病毒儿童提供医院和社区服务的使用情况及成本
Pharmacoeconomics. 2000 Jan;17(1):53-69. doi: 10.2165/00019053-200017010-00004.
3
The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs.1996年英格兰艾滋病病毒服务提供的使用情况与成本。国家前瞻性监测系统(NPMS)指导小组及NPMS成本工作小组
Pharmacoeconomics. 1998 Dec;14(6):639-52. doi: 10.2165/00019053-199814060-00005.
4
Indirect cost of HIV infection in England.英国艾滋病毒感染的间接成本。
Clin Ther. 2000 Nov;22(11):1333-45. doi: 10.1016/s0149-2918(00)83030-1.
5
Demograghic and socio-economic determinants of community and hospital services costs for people with HIV/AIDS in London.伦敦艾滋病毒/艾滋病患者社区及医院服务成本的人口统计学和社会经济决定因素
Soc Sci Med. 1999 May;48(10):1433-40. doi: 10.1016/s0277-9536(98)00447-x.
6
Cost and utilisation of community services for people with HIV infection in London.伦敦艾滋病毒感染者社区服务的成本与利用情况
Health Trends. 1995;27(2):62-8.
7
Hospital service utilization by HIV/AIDS patients and their management cost in a provincial genitourinary medicine department.某省级泌尿生殖医学科艾滋病毒/艾滋病患者的医院服务利用情况及其管理成本
Int J STD AIDS. 1995 Sep-Oct;6(5):336-44. doi: 10.1177/095646249500600506.
8
The costs and effectiveness of surveillance of communicable disease: a case study of HIV and AIDS in England and Wales.
J Public Health Med. 1996 Dec;18(4):415-22. doi: 10.1093/oxfordjournals.pubmed.a024539.
9
The costs of epilepsy misdiagnosis in England and Wales.英格兰和威尔士癫痫误诊的成本。
Seizure. 2006 Dec;15(8):598-605. doi: 10.1016/j.seizure.2006.08.005. Epub 2006 Sep 29.
10
[Study on the utilization of health services and costs of hospital-based medical care for 29 patients with HIV/AIDS in China].[中国29例艾滋病病毒/艾滋病患者的卫生服务利用及住院医疗费用研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2003 May;24(5):393-6.

引用本文的文献

1
Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.利用 CD4 细胞计数预测基于达芦那韦的高效抗逆转录病毒治疗第一年的 HIV 护理直接成本:POWER 的证据。
Pharmacoeconomics. 2010;28 Suppl 1:169-81. doi: 10.2165/11587510-000000000-00000.
2
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.比利时、意大利、瑞典和英国治疗经验丰富、洛匹那韦/利托那韦初治、对蛋白酶抑制剂耐药的 HIV 感染成人中每日两次使用达芦那韦/利托那韦 600/100 mg 的成本效益。
Pharmacoeconomics. 2010;28 Suppl 1:147-67. doi: 10.2165/11587500-000000000-00000.
3

本文引用的文献

1
Treating AIDS: the economic issues.治疗艾滋病:经济问题。
Health Policy. 1988 Aug;10(1):1-19. doi: 10.1016/0168-8510(88)90083-8.
2
The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe.艾滋病毒感染者或艾滋病患者的治疗与护理成本:欧洲标准化成本框架的制定
Health Policy. 1993 Apr;24(1):55-70. doi: 10.1016/0168-8510(93)90088-7.
3
Economic evaluation in health care: is there a role for cost-benefit analysis?医疗保健中的经济评估:成本效益分析有作用吗?
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK.在比利时、意大利、瑞典和英国,接受过蛋白酶抑制剂治疗的 HIV-1 感染成年人中,每日两次给予达芦那韦/利托那韦 600/100mg 的成本效益。
Pharmacoeconomics. 2010;28 Suppl 1:107-28. doi: 10.2165/11587480-000000000-00000.
4
Cost-of-illness studies : a review of current methods.疾病成本研究:当前方法综述
Pharmacoeconomics. 2006;24(9):869-90. doi: 10.2165/00019053-200624090-00005.
5
Efavirenz: a pharmacoeconomic review of its use in HIV infection.依非韦伦:对其在HIV感染治疗中应用的药物经济学综述
Pharmacoeconomics. 2001;19(4):421-36. doi: 10.2165/00019053-200119040-00009.
6
The cost of HIV treatment and care. A global review.艾滋病毒治疗与护理的成本。一项全球综述。
Pharmacoeconomics. 2001 Jan;19(1):13-39. doi: 10.2165/00019053-200119010-00002.
7
Healthcare Economics in HIV.艾滋病的卫生保健经济学
Curr Infect Dis Rep. 2000 Aug;2(4):371-375. doi: 10.1007/s11908-000-0018-8.
8
Cost effectiveness of epoetin-alpha to augment preoperative autologous blood donation in elective cardiac surgery.促红细胞生成素α增加择期心脏手术术前自体血捐献的成本效益分析。
Pharmacoeconomics. 2000 Aug;18(2):161-71. doi: 10.2165/00019053-200018020-00006.
9
Cost effectiveness of combination HIV therapy: 3 years later.联合抗逆转录病毒疗法的成本效益:三年后
Pharmacoeconomics. 2000 Apr;17(4):325-30. doi: 10.2165/00019053-200017040-00002.
10
Lamivudine reduces healthcare resource use when added to zidovudine-containing regimens in patients with HIV infection.
Pharmacoeconomics. 1999;15 Suppl 1:13-22. doi: 10.2165/00019053-199915001-00002.
Health Policy. 1991 Feb;17(1):1-23. doi: 10.1016/0168-8510(91)90114-d.
4
Hospital cost for patients with HIV infection in a university hospital in The Netherlands.
Health Policy. 1990;16(1):43-54. doi: 10.1016/0168-8510(90)90440-o.
5
Improved survival from diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays.英国成年艾滋病病例诊断后的生存率提高以及报告延迟导致的偏差。
AIDS. 1993 Mar;7(3):415-20. doi: 10.1097/00002030-199303000-00017.
6
The lifetime cost of treating a person with HIV.治疗一名艾滋病毒感染者的终身费用。
JAMA. 1993 Jul 28;270(4):474-8.
7
Defining and measuring the costs of the HIV epidemic to business firms.界定并衡量艾滋病流行对商业公司造成的成本。
Public Health Rep. 1994 May-Jun;109(3):311-8.
8
Costs to business for an HIV-infected worker.
Inquiry. 1994 Spring;31(1):76-88.
9
Changing use of hospital services and costs at a London AIDS referral centre, 1983-1989.1983 - 1989年伦敦艾滋病转诊中心医院服务的使用变化及费用情况
AIDS. 1994 Mar;8(3):367-77. doi: 10.1097/00002030-199403000-00012.
10
AIDS treatment costs during the last months of life: evidence from the ACSUS.生命最后几个月的艾滋病治疗费用:来自美国社区调查的证据。
Health Serv Res. 1994 Dec;29(5):569-81.